Tuesday, April 24, 2018
 
 
Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Committee on Appropriations on FDA's Fiscal Year 2019 budget
SILVER SPRING, Md., April 24, 2018 /PRNewswire-USNewswire/ -- Chairman Hoeven, Ranking Member Merkley and members of the Subcommittee. Thank you for the invitation to testify today to discuss the President's Fiscal Year (FY) 2019 Budget request and for this Subcommittee's continued, strong support of the FDA.
 
Amgen Reports First Quarter 2018 Financial Results
THOUSAND OAKS, Calif., April 24, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2018. Key results include:
 
Mirati Therapeutics Announces Progress Of Lead Programs And Provides Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials
SAN DIEGO, April 24, 2018 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX) (the Company or Mirati), a clinical-stage targeted oncology company, today provided a progress update on its lead development programs and announced updated, positive clinical trial data for sitravatinib, a spectrum selective kinase inhibitor, .....
 
NewYork-Presbyterian Opens A World-Class Center For Ambulatory Care: NewYork-Presbyterian David H. Koch Center
NEW YORK, April 24, 2018 /PRNewswire/ -- Today, NewYork-Presbyterian celebrated the opening of the NewYork-Presbyterian David H. Koch Center, a world-class ambulatory care center that combines innovative clinical approaches an.....
 
Joe Patrina Launches Book on Defeating Breast Cancer Organically; No surgery, chemotherapy or radiation.
April 24, 2018 - Joe Patrina is thrilled to announce the launch of his book, “Defeating Breast Cancer Organically; No surgery, chemotherapy or radiatio...
 
American Airlines, Stand Up To Cancer, & Marvel Studios' Avengers: Infinity War Join Together In The Battle Against Cancer To Unveil Custom-Wrapped Plane
LOS ANGELES, April 24, 2018 /PRNewswire/ -- American Airlines, Stand Up To Cancer (SU2C) and Marvel Studios unveiled the next element in their collaboration, yesterday—an aircraft wrapped with a special graphic featuring Marvel Studios' Avengers: Infinity War heroes alongside the Stand Up To Cancer logo and images of SU2C re.....
 



Global Brachytherapy Markets Report 2016-2018 & 2024 - Recent Industry Activity, Key Findings & Focus on Key Players
DUBLIN, April 24, 2018 /PRNewswire/ --
 
Soccer Heading--Not Collisions--Cognitively Impairs Players
BRONX, N.Y., April 24, 2018 /PRNewswire-USNewswire/ -- Worse cognitive function in soccer players stems mainly from frequent ball heading rather than unintentional head impacts due to collisions, researchers at Albert Einstein College.....
 
Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria
PEABODY, Mass., April 24, 2018 /PRNewswire-USNewswire/ -- A new study published in The Journal of the American Medical Association (JAMA) reports that lonafarnib, a farnesyltransferase inhibitor (FTI), helped extend survival in children with Hutchinson-Gilford Progeria Syndrome (HGPS), or Progeria, an ultra-rare and fa.....
 
/R E P E A T -- Oral Cancer Screening Day "Shining the Light on Oral Cancer"/
EDMONTON, April 19, 2018 /CNW/ - Drs. Brandon Wong, Neena Lakhanpal and Michelle Chong-Gragasin are hosting an oral cancer screening awareness week on April 23-27, 2018 leading up to a complimentary open-.....
 
Veterinary Pain Management Market to Grow at 8.0% CAGR to 2023
PUNE, India, April 24, 2018 /PRNewswire/ --
 
Lin BioScience Announces FDA Orphan Drug Designation for LBS-007 for the Treatment of Acute Lymphoblastic Leukemia
SAN DIEGO, April 24, 2018 /PRNewswire/ -- Lin BioScience, a drug development company targeting unmet clinical needs in oncology, ophthalmology and metabolic diseases, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to LBS-007 for acute lymphoblastic leukemia (ALL). ALL .....
 
IMPACT Melanoma Serves Colorado College Skin Cancer Prevention Initiative with Free Sunscreen Dispensers For Multiple Campuses
CONCORD, Mass., April 24, 2018 /PRNewswire-USNewswire/ -- IMPACT Melanoma, a non-profit aimed at providing education, prevention, and support for the most serious form of skin cancer, has provided sunscreen dispensers and educational awareness materi.....
 


 
 
 
 
 
 
 
 
Seniors

Drugs
  • Centene Corporation Reports 2018 First Quarter Results And Adjusts 2018 Guidance
  • Pain Management Device Market Factor Analysis 2018 - Technological and Product Development to Drive the Global Industry by 2023
  • Global Medical Device Market 2018 with Forecasts to 2023 - Driven by Healthcare Expenditure / Technological Development / Aging Population / Chronic Diseases
  • Orthodontic Supplies Market to Hit 8.9% CAGR to 2023, Led by Align Technology, Inc. (US), 3M Company (US), and Danaher Corporation (US)
  • New Orleans' GAINSWave Offers GAINSWave® in Louisiana

    Cancer
  • MOLOGEN AG: Announcement of the new dates for the publication of the Annual Financial Statements 2017 and the 2018 Annual General Meeting
  • Diagnosis (DX) Share Life - Life Just Got Personal
  • Mary Washington Healthcare Adopts Medpricer's Purchased Services Solutions
  • Mercy Health Standardizes Clinical Communication at 23 Provider Facilities with PerfectServe
  • Eceptionist Scheduling Software For Cellular Therapy - Project Implementation Abstract To Be Presented At The Annual ISCT Conference In Montreal
  •  
     
     
     
     
     





    About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines